Atish Dipankar Choudhury, Caiwei Zhong, Wanling Xie, Julia Bonavolonta, Claire Leisner, Bicky Thapa, Xiao X. Wei, Praful Ravi, Daniel Aaron Roberts, Jacob Peter Zaemes, Martin T. King. "Comeback from long-course ADT with relugolix (rel) and darolutamide (daro) in hormone-sensitive prostate cancer (PC) (CLEARED).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5083